InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by Murphy Matthew B., Conseiller Juridique Général. Director active across 1 companies, notably Nautilus Biotechnology, Inc.. In total, 3 filings have been logged. Total volume traded: €64k. The latest transaction was disclosed on 12 May 2022 — Attribution. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations3 total
€31,60110,000 shares@ €3.16010.013% mcap32.9% of flow
Common Stock
SEC:0001808805-22-000056:0·
€32,2135,000 shares@ €6.4427100.0% of flow
Common Stock
SEC:0001808805-21-000010·
Ideal exit: 10 May 2022 (T+270)
€32,2135,000 shares@ €6.44270.013% mcap33.5% of flow
Common Stock
SEC:0001808805-21-000010:0·
Ideal exit: 10 May 2022 (T+270)
3 of 3 declarations
About Murphy Matthew B.
Matthew B. Murphy is the General Counsel at Nautilus Biotechnology, Inc. In this role, he is responsible for the company's legal affairs and compliance. His expertise in business law is essential for advising management on legal and regulatory matters. He plays a key role in managing legal risks and protecting the company's interests.
